July 2, 2012 - Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes (MDS). The findings published online July 2 in the journal Blood.